Win Advisors, Inc Moderna, Inc. Transaction History

Win Advisors, Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $25,806 - $45,788	218 Added 495.45%	262 $47,000
Q2 2022 Jul 18, 2022	SELL	$117.13 - $176.59 $134,582 - $202,901	-1,149 Reduced 96.31%	44 $7,000
Q1 2022 May 13, 2022	BUY	$126.46 - $235.05 $150,866 - $280,414	1,193 New	1,193 $206,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Win Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Win Advisors, Inc with notifications on news.